|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/382 | |
| A61K 31/4025 | |||
| A61K 31/498 | |||
| A61K 31/5578 | |||
| A61K 9/00 | |||
| A61K 31/5377 |
| (11) | Number of the document | 2555749 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11714895.7 |
| Date of filing the European patent application | 2011-04-05 | |
| (97) | Date of publication of the European application | 2013-02-13 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/031265 |
| Date | 2011-04-05 |
| (87) | Number | WO 2011/127064 |
| Date | 2011-10-13 |
| (30) | Number | Date | Country code |
| 321422 P | 2010-04-06 | US |
| (72) |
SHI, Ruwen, US
HUGHES, Patrick M., US
BURKE, James A., US
ROBINSON, Michael R., US
LIU, Hui, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | SUSTAINED-RELEASE RESERVOIR IMPLANTS FOR INTRACAMERAL DRUG DELIVERY |
| SUSTAINED-RELEASE RESERVOIR IMPLANTS FOR INTRACAMERAL DRUG DELIVERY |